Real‐World Adherence in Patients With Metastatic Colorectal Cancer Treated With Trifluridine Plus Tipiracil or Regorafenib

Oncologist - United States
doi 10.1634/theoncologist.2019-0240
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Real-World Treatment Patterns Among Patients With Colorectal Cancer Treated With Trifluridine/Tipiracil and Regorafenib

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

Factors Associated With Regorafenib Adherence With Metastatic Colorectal Cancer

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2019English

Duration of Previous Treatment as a Prognostic Factor in Metastatic Colorectal Cancer Treated With Trifluridine/Tipiracil

Molecular and Clinical Oncology
Cancer ResearchOncology
2018English

A Retrospective Study of Trifluridine/Tipiracil in Pretreated Metastatic Colorectal Cancer Patients in Clinical Practice

Colorectal Cancer
OncologyGastroenterology
2018English

Cost Effectiveness of Trifluridine/Tipiracil for Previously Treated Metastatic Colorectal Cancer in England and Wales

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

Emerging Combination Therapies for Metastatic Colorectal Cancer &Ndash; Impact of Trifluridine/Tipiracil

Cancer Management and Research
Oncology
2017English

Large‐Scale, Prospective Observational Study of Regorafenib in Japanese Patients With Metastatic Colorectal Cancer in a Real‐World Clinical Setting

Oncologist
Cancer ResearchMedicineOncology
2019English

Prescriber Adherence to Antiemetic Guidelines With the New Agent Trifluridine-Tipiracil

Journal of Community and Supportive Oncology
OncologyHematology
2017English

Regorafenib Adjusted Dose for Chilean Patients With Chemoresistant Metastatic Colorectal Cancer: A Case Series

ecancermedicalscience
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy